Cardiac Dimensions, a medical device company based in Kirkland, Wash., landed $35 million to support testing and marketing of its system to treat mitral valve regurgitation. Mitral valve regurgitation ...

Funds Expected to Support Enrollment in U.S. Pivotal EMPOWER Trial and European Commercial Expansion for Carillon Mitral Contour System® KIRKLAND, Wash.--(BUSINESS WIRE)--Cardiac Dimensions®, a leader ...

Satya Shreenivas, MD, has been appointed chief medical officer of Cardiac Dimensions, a medical equipment manufacturing company focusing on minimally invasive treatment options for patients who have ...

KIRKLAND, Wash.--(BUSINESS WIRE)--Cardiac Dimensions ®, a leader in minimally invasive treatments for heart failure and functional mitral regurgitation (FMR), today announced the close of an ...

Cardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s mitral valve repair device. The round was led by investment management firm ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Kirkland-based company is ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company makes a device to ...

Cardiac Dimensions Inc. launched the Empower trial of its Carillon mitral contour system for the treatment of heart failure patients with early-stage functional mitral regurgitation. The company ...